Amsterdam - Delayed Quote EUR
Vivoryon Therapeutics N.V. (VVY.AS)
1.7760
-0.0340
(-1.88%)
At close: April 25 at 5:35:20 PM GMT+2
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
30,829
31,378
24,520
29,751
Total Liabilities Net Minority Interest
4,547
4,872
7,963
3,530
Total Equity Gross Minority Interest
26,282
26,506
16,557
26,221
Total Capitalization
26,282
26,506
16,557
26,221
Common Stock Equity
26,282
26,506
16,557
26,221
Capital Lease Obligations
38
132
224
314
Net Tangible Assets
25,341
26,012
16,024
25,656
Working Capital
26,630
27,429
15,178
27,468
Invested Capital
26,282
26,506
16,557
26,221
Tangible Book Value
25,341
26,012
16,024
25,656
Total Debt
38
132
224
314
Share Issued
26,066.8080
24,105.2780
20,050.4820
19,975.4820
Ordinary Shares Number
26,066.8080
24,105.2780
20,050.4820
19,975.4820
12/31/2020 - 10/27/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DBP-B.ST Double Bond Pharmaceutical Int.
0.2860
+4.76%
2QV0.F Chemomab Therapeutics Ltd.
1.0900
+2.83%
PBN.F Alterity Therapeutics Limited
0.0045
+12.50%
ZR8.F Oncodesign Precision Medicine Société anonyme
0.6820
0.00%
6XY.F HBM Holdings Limited
0.9000
+5.88%
MARI.VI Marinomed Biotech AG
12.40
+3.33%
ALOPM.PA Oncodesign Precision Medicine Société anonyme
0.3800
+2.43%
VT6.F Voyager Therapeutics, Inc.
3.0180
-2.96%
ALTME.PA TME Pharma N.V.
0.0644
0.00%
IMMU.ST Mendus AB (publ)
4.9750
+2.26%